Profile
Profile
Profile
Culture
Culture
Core team
Core team
Qualification
Qualification
Technology
Technology
Cooperation
Cooperation
Clinical testing service
Clinical testing service
Clinical testing service
Tumor personalized liquid biopsy Lung cancer detection Gastric and colorectal cancer treatment target detection Female gynecological oncology Pan-cancerous solid tumor (multi-cancer) Chemotherapy guidance Hereditary tumor detection
Tumor personalized clinical testing Lung cancer detection Gastric and colorectal cancer treatment target detection Female gynecological oncology Immunity therapy Pan-cancerous solid tumor (multi-cancer) Chemotherapy guidance Hereditary tumor detection
Health checkup products
Health checkup products
Rui Health
Ryan
Cutting-edge research services
Cutting-edge research services
Single cell sequencing
T cell immune library sequencing
New antigen detection
Tumor personalized science research
High-throughput multi-omics sequencing and analysis services
News
News
News
Knowledge
Knowledge
Recruitment
Recruitment
Recruitment
Staff style
Staff style
Search

APP download

WeChat

Tel: +86-571-89360709  E-mail: service@repugene.com
Address: 21-23, Health Valley, No. 1500, Wenyi West Road, Yuhang District, Hangzhou, Zhejiang, China
Copyright: Hangzhou Repugene Technology Co., Ltd.   Powered by www.300.cn  
浙ICP备16003170号

Hangzhou Repugene Technology Co., Ltd.  is a high-tech advanced biomedical research and development enterprise with the team of Dr. Haigui.

core team

Core Team

Ms. Lou Shengqiong
Ms. Lou Shengqiong

Ms. Lou Shengqiong
Founder of the company, general manager of Rip Gene;
US MBA;
Vice President of Zhejiang Women Entrepreneurs Association;
Executive President of Hangzhou Women Entrepreneurs Association;
Senior investment manager;
Successfully established and managed the Great Wall International Restaurant Chain Group;
Invested in a number of domestic enterprises, covering biomedicine, information security and other fields, its investment in Beida Pharmaceuticals was successfully listed on the Shenzhen GEM in 2016.
Dr. Ding Liming
Dr. Ding Liming

Dr. Ding Liming
Founder of the company, senior consultant of Rip Gene;
NPC deputies, famous returnees scholars, national “Thousand Talents Program” experts, leading figures in Chinese pharmaceutical innovation, and also winners of the National Progress Award;
Fully leading Beida Pharmaceutical to complete the listing of “Kemena”, a molecular target drug for lung cancer with completely independent intellectual property rights, to break the monopoly of foreign products in this field;
Investment holding Xcovery, Kananji Medicine, Medical Kono Bio, Beida Anjin and other pharmaceutical companies.
Page up
1